Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2022
Foundery is a venture studio fund focused on investing in first-in-class immunotherapies sourced from premier research universities. Foundery validates and develops early drug concepts in wholly-owned labs with in-house scientists to generate advanced development candidate (DC) packages in collaboration with university investigators. NewCos are built around DCs and sold to biopharma partners for downstream clinical development.
2020
Life Science Angels (LSA) is a not-for-profit corporation with 130-150 accredited investor members and 12-18 highly qualified fellows. LSA has invested >$60M in over 100 startups in the biopharma, medical device, diagnostics and digital health sectors. Companies seeking funding are encouraged to apply via www.lifescienceangels.com/apply-for-funding. Investments: - Avisi Technologies - Celldom - InnoSIGN - Noctrix Health - Pelvital - Renata Medical - Saccharo - TRIO Pharmaceuticals - VisiCELL Medical
2020
2020
Hyphen Capital is a syndicate of accredited angel investors which invests in multi-stage companies started by Asian American and Pacific Islander founders. Investments: - Arc - Baobab Studios - Canopy - Concha Labs - Dang Foods - Elation Health - Hero Bread - Homecourt - Italic - Mascot - Mayvenn - Prime Roots - Pry Financials - Rocket Dollar - SafeBase - Slope - Snapcommerce - Unit21 - Yumi
2020
The Berkeley Angel Network (BAN) is a group of angel investors who are alumni, faculty and former faculty of UC Berkeley. Companies seeking funding may refer to the following process document: https://berkeleyangelnetwork.com/wp-content/uploads/2017/08/BAN-Berkeley-Angel-Network-Application-Process-20150409-GAW.pdf Investments: - Nalu Bio - Noninvasix - Sensorygen
2022 - 2022
2022 - 2022
Tranquis is an SR One/Remiges/Vivo backed clinical-stage biopharmaceutical company developing a portfolio of small molecule therapeutics based on its unique approach of reprogramming dysfunctional myeloid immune cells to restore normal cell homeostasis and function.
2019 - 2022
2019 - 2022
Horizon was a global biotechnology company focused on the discovery, development and commercialization of medicines that address critical needs for people impacted by rare, autoimmune and severe inflammatory diseases. Amgen completed its $27.8B acquisition of Horizon in October 2023.
2012 - 2022
2012 - 2022
Selected Investments: - Blueberry Pediatrics - LB Pharmaceuticals - Root Applied Science - Sushiritto | Mochiko Mochi Pizza - TauRx Therapeutics - Vanity | Suite26
2015 - 2019
2015 - 2019
Allexcel is the exclusive marketer and master distributor of Red Bull Energy Drink (Asian SKUs) in Malaysia.
2012 - 2015
2012 - 2015
Allswell is the exclusive marketer and master distributor of Red Bull Energy Drink (Asian SKUs) in Singapore and Brunei.
2010 - 2012
2010 - 2012
Evercore (NYSE: EVR) is a premier global independent investment banking advisory firm. The Firm dedicated to helping its clients achieve superior results through trusted independent and innovative advice on matters of strategic significance to boards of directors, management teams and shareholders, including mergers and acquisitions, strategic shareholder advisory, restructurings, and capital structure. Evercore also assists clients in raising public and private capital and delivers equity research and equity sales and agency trading execution, in addition to providing wealth and investment management services to high net worth and institutional investors.